SignatureFD’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
657
+17
| +3% | +$2.93K | ﹤0.01% | 1184 |
|
|
2025
Q1 | $99.8K | Sell |
640
-52
| -8% | -$8.11K | ﹤0.01% | 1212 |
|
|
2024
Q4 | $95.3K | Buy |
692
+6
| +0.9% | +$826 | ﹤0.01% | 1250 |
|
|
2024
Q3 | $102K | Buy |
686
+80
| +13% | +$11.9K | ﹤0.01% | 1205 |
|
|
2024
Q2 | $82.6K | Sell |
606
-46
| -7% | -$6.27K | ﹤0.01% | 1269 |
|
|
2024
Q1 | $98.6K | Buy |
652
+89
| +16% | +$13.5K | ﹤0.01% | 1197 |
|
|
2023
Q4 | $70.9K | Sell |
563
-235
| -29% | -$29.6K | ﹤0.01% | 1300 |
|
|
2023
Q3 | $74.7K | Buy |
798
+193
| +32% | +$18.1K | ﹤0.01% | 1202 |
|
|
2023
Q2 | $54K | Sell |
605
-672
| -53% | -$60K | ﹤0.01% | 1381 |
|
|
2023
Q1 | $137K | Sell |
1,277
-64
| -5% | -$6.86K | ﹤0.01% | 880 |
|
|
2022
Q4 | $164K | Buy |
1,341
+49
| +4% | +$5.98K | ﹤0.01% | 780 |
|
|
2022
Q3 | $133K | Buy |
1,292
+500
| +63% | +$51.5K | ﹤0.01% | 821 |
|
|
2022
Q2 | $74K | Buy |
792
+529
| +201% | +$49.4K | ﹤0.01% | 1110 |
|
|
2022
Q1 | $31K | Sell |
263
-393
| -60% | -$46.3K | ﹤0.01% | 1603 |
|
|
2021
Q4 | $88K | Sell |
656
-2
| -0.3% | -$268 | ﹤0.01% | 1077 |
|
|
2021
Q3 | $105K | Buy |
658
+176
| +37% | +$28.1K | ﹤0.01% | 945 |
|
|
2021
Q2 | $63K | Buy |
482
+125
| +35% | +$16.3K | ﹤0.01% | 1160 |
|
|
2021
Q1 | $46K | Buy |
357
+74
| +26% | +$9.54K | ﹤0.01% | 1202 |
|
|
2020
Q4 | $47K | Buy |
283
+61
| +27% | +$10.1K | ﹤0.01% | 1107 |
|
|
2020
Q3 | $34K | Buy |
222
+147
| +196% | +$22.5K | ﹤0.01% | 1138 |
|
|
2020
Q2 | $11K | Buy |
75
+43
| +134% | +$6.31K | ﹤0.01% | 1524 |
|
|
2020
Q1 | $4K | Buy |
+32
| New | +$4K | ﹤0.01% | 1713 |
|